Cunyi Shen, W. Tan, Xi Li, Jingyao Zhang, Qingguang Liu, Chang Liu, Zheng Wu, Zheng-Guo Wang
{"title":"Management of novel coronavirus infection in ICU","authors":"Cunyi Shen, W. Tan, Xi Li, Jingyao Zhang, Qingguang Liu, Chang Liu, Zheng Wu, Zheng-Guo Wang","doi":"10.7652/JDYXB202004004","DOIUrl":null,"url":null,"abstract":"Coronavirus disease 2019 (COVID-19) is highly infectious and seriously harmful to human health. According to the clinical characteristics of COVID-19, it can be classified into mild, moderate, severe and critical ones. The treatment for critical cases is an important factor of reducing the mortality rate of the disease and is always dependent on the intensive care unit (ICU). The ICU therapy strategies involve not only curing the critical cases, but also avoiding cross infection in the same ward. Therefore, we have formulated detailed response management strategies, including the establishment of core groups, standardization of diagnosis and treatment process, strengthening personnel management, multimodal training assessment, and overall allocation of protection materials. We hope the strategies can provide reference for relevant ICUs.","PeriodicalId":35774,"journal":{"name":"Hsi-An Chiao Tung Ta Hsueh/Journal of Xi''an Jiaotong University","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hsi-An Chiao Tung Ta Hsueh/Journal of Xi''an Jiaotong University","FirstCategoryId":"1089","ListUrlMain":"https://doi.org/10.7652/JDYXB202004004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Engineering","Score":null,"Total":0}
引用次数: 0
Abstract
Coronavirus disease 2019 (COVID-19) is highly infectious and seriously harmful to human health. According to the clinical characteristics of COVID-19, it can be classified into mild, moderate, severe and critical ones. The treatment for critical cases is an important factor of reducing the mortality rate of the disease and is always dependent on the intensive care unit (ICU). The ICU therapy strategies involve not only curing the critical cases, but also avoiding cross infection in the same ward. Therefore, we have formulated detailed response management strategies, including the establishment of core groups, standardization of diagnosis and treatment process, strengthening personnel management, multimodal training assessment, and overall allocation of protection materials. We hope the strategies can provide reference for relevant ICUs.